Generated by GPT-5-mini| European Cancer Information System | |
|---|---|
| Name | European Cancer Information System |
| Abbreviation | ECIS |
| Formation | 1990s |
| Type | Health information system |
| Location | Brussels, Belgium |
| Parent organization | European Commission |
European Cancer Information System
The European Cancer Information System provides population-based cancer statistics and analyses for countries across Europe and partners. It aggregates registry data to inform policy for institutions such as the European Commission, World Health Organization, International Agency for Research on Cancer, European Parliament, and national ministries like the Ministry of Health (France) and Bundesministerium für Gesundheit. The system supports research tied to initiatives including the European Medicines Agency, Horizon 2020, Horizon Europe, European Commission Directorate-General for Health and Food Safety, and the European Centre for Disease Prevention and Control.
The system offers standardized datasets on incidence, mortality, survival, prevalence, and projections used by agencies such as the International Agency for Research on Cancer and the World Health Organization for comparisons across registries like the Surveillance, Epidemiology, and End Results Program and national sources including the National Cancer Institute (United States), Instituto Nacional de Estadística (Spain), Istituto Superiore di Sanità, Statistisches Bundesamt (Germany). It provides interactive tools for stakeholders including the European Parliament, Council of the European Union, European Commission, Organisation for Economic Co-operation and Development, and foundations such as the Wellcome Trust and Bill & Melinda Gates Foundation. The platform aligns methodologies with programs including CONCORD, EUROCARE, EUREG, and guidelines used by the European Respiratory Society and European Society for Medical Oncology.
Origins trace to collaborative efforts between the International Agency for Research on Cancer, the European Commission, and national registries such as the Northern and Yorkshire Cancer Registry and Information Service and Registro Tumori Italiano. Early milestones include projects funded under Framework Programme 5 and collaborations with the European Network of Cancer Registries and networks like EUROCARE and CONCORD. Subsequent development involved partnerships with the European Centre for Disease Prevention and Control, the European Parliament, the Council of the European Union and research consortia supported by Horizon 2020 and Horizon Europe. High-profile events influencing its scope included summits hosted by the European Commission and reports by the World Health Organization and the Organisation for Economic Co-operation and Development.
Governance combines oversight by the European Commission and technical direction from the International Agency for Research on Cancer and the European Cancer Organisation. Advisory bodies include representatives from national registries such as the Nordic Cancer Registries, the Irish Cancer Registry, the Netherlands Comprehensive Cancer Organisation, and stakeholder groups including patient organizations like European Cancer Patient Coalition and professional bodies such as the European Society for Medical Oncology and the European Public Health Association. Funding channels include EU instruments like Horizon Europe, allocations from the European Commission Directorate-General for Health and Food Safety, and in-kind contributions from institutes such as Istituto Superiore di Sanità and Karolinska Institutet.
Data are collated from population-based registries including the Registro Tumori Italiano, Cancer Registry of Norway, Finnish Cancer Registry, and regional centres such as the Lombardy Cancer Registry and Greater Manchester Cancer Registry. Methodological standards draw on manuals from the International Agency for Research on Cancer, revisions of the International Classification of Diseases, coding systems maintained by the World Health Organization, and survival analysis protocols used in EUROCARE and CONCORD. Statistical techniques reference models applied by the Office for National Statistics (UK), projection frameworks similar to those of the Organisation for Economic Co-operation and Development, and data linkage practices seen at the National Cancer Institute (United States). Quality assurance engages audits from agencies like the European Medicines Agency and partnerships with academic centres including University College London and Karolinska Institutet.
Services include interactive web tools for incidence and mortality mapping used by policymakers in the European Parliament and researchers at institutions such as the International Agency for Research on Cancer, downloadable databases referenced by the World Health Organization, survival estimates comparable with CONCORD outputs, and projection modules similar to those of the Office for National Statistics (UK). Programs support public health campaigns run alongside the European Commission Directorate-General for Health and Food Safety, screening evaluations linked to guidelines from the European Commission, and collaborative research projects funded by Horizon Europe and coordinated with networks like the European Network of Cancer Registries.
Outputs inform legislation debated in the European Parliament and policy directives issued by the European Commission and national ministries such as the Bundesministerium für Gesundheit and Ministry of Health (Spain). Data underpin clinical guidelines referenced by the European Society for Medical Oncology and resource planning used by health systems such as the National Health Service (England), reimbursement decisions influenced by the European Medicines Agency, and advocacy by organisations like the European Cancer Patient Coalition and the Union for International Cancer Control. Academic research leveraging the system has been published by centres including University College London, Karolinska Institutet, Institut Curie, and the University of Barcelona.
Challenges include harmonizing registry practices across members of the European Union and neighbouring states, interoperability issues similar to those tackled by the European Health Data Space, legal constraints involving instruments like the General Data Protection Regulation and coordination with institutions such as the European Data Protection Supervisor. Future development plans involve integration with initiatives supported by Horizon Europe, enhanced analytics drawing on methods used at Wellcome Trust funded projects and machine learning research at ETH Zurich and Imperial College London, and deeper collaboration with public health agencies including the European Centre for Disease Prevention and Control and the World Health Organization.
Category:Health information systems